As of 2025-10-18, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (7.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.26 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -238.6%.
The range of the Relative Valuation is (5.75) - (9.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (5.75) - (9.62) | (7.29) |
| Upside | -209.2% - -282.8% | -238.6% |
| Date | P/E |
| 2025-10-16 | -6.38 |
| 2025-10-15 | -6.70 |
| 2025-10-14 | -6.32 |
| 2025-10-13 | -6.21 |
| 2025-10-10 | -6.38 |
| 2025-10-09 | -6.71 |
| 2025-10-08 | -6.65 |
| 2025-10-07 | -6.64 |
| 2025-10-06 | -6.52 |
| 2025-10-03 | -6.79 |
| 2025-10-02 | -6.30 |
| 2025-10-01 | -6.20 |
| 2025-09-30 | -6.18 |
| 2025-09-29 | -6.17 |
| 2025-09-26 | -6.00 |
| 2025-09-25 | -5.86 |
| 2025-09-24 | -5.93 |
| 2025-09-23 | -6.05 |
| 2025-09-22 | -5.86 |
| 2025-09-19 | -5.83 |
| 2025-09-18 | -5.93 |
| 2025-09-17 | -5.80 |
| 2025-09-16 | -5.87 |
| 2025-09-15 | -6.02 |
| 2025-09-12 | -6.38 |
| 2025-09-11 | -6.58 |
| 2025-09-10 | -6.56 |
| 2025-09-09 | -6.82 |
| 2025-09-08 | -6.75 |
| 2025-09-05 | -6.58 |
| 2025-09-04 | -6.54 |
| 2025-09-03 | -6.90 |
| 2025-09-02 | -6.80 |
| 2025-08-29 | -6.91 |
| 2025-08-28 | -6.93 |
| 2025-08-27 | -6.92 |
| 2025-08-26 | -6.97 |
| 2025-08-25 | -6.83 |
| 2025-08-22 | -6.88 |
| 2025-08-21 | -6.96 |
| 2025-08-20 | -6.66 |
| 2025-08-19 | -6.63 |
| 2025-08-18 | -6.44 |
| 2025-08-15 | -6.38 |
| 2025-08-14 | -6.27 |
| 2025-08-13 | -6.35 |
| 2025-08-12 | -6.34 |
| 2025-08-11 | -6.21 |
| 2025-08-08 | -6.22 |
| 2025-08-07 | -6.12 |